HIV and syphilis coinfection in pregnancy and adverse birth outcomes in Uganda

Mehal Churiwal, Timothy Mwanje Kintu, Onesmus Byamukama, Ingrid V Bassett, Mark J Siedner, Anacret Byamukama, Edna Tindimwebwa, Pooja Chitneni, Julian Adong, Elias Kumbakumba, Stephen Asiimwe, Joseph Ngonzi, Lisa M Bebell
{"title":"HIV and syphilis coinfection in pregnancy and adverse birth outcomes in Uganda","authors":"Mehal Churiwal, Timothy Mwanje Kintu, Onesmus Byamukama, Ingrid V Bassett, Mark J Siedner, Anacret Byamukama, Edna Tindimwebwa, Pooja Chitneni, Julian Adong, Elias Kumbakumba, Stephen Asiimwe, Joseph Ngonzi, Lisa M Bebell","doi":"10.1093/infdis/jiaf453","DOIUrl":null,"url":null,"abstract":"Background Despite increasing syphilis incidence worldwide, little is known about the combined impact of maternal HIV and syphilis coinfection. We determined effects of HIV/syphilis coinfection in pregnancy on birth outcomes. Methods We conducted two prospective birth cohort studies of pregnant women delivering in Uganda from 2017-2023. Our primary outcome was birthweight. Our secondary outcome was a composite adverse birth outcome, including low birthweight (<2.5kg), stillbirth, early neonatal death, or 5-minute APGAR<7. We compared outcomes by HIV and Treponema pallidum particle agglutination assay (TPPA) seropositivity and fitted multivariable logistic regression models to determine associations with outcomes. Results Overall, TPPA seroprevalence was 12% (118/967) in this cohort comprised of 50% women with HIV (WHIV); 19% (94/483) among WHIV and 5% (24/484) among women without HIV. Only 48% of TPPA seropositive women reported syphilis testing during antenatal care. Combined stillbirth and early neonatal death were higher among TPPA seropositive participants: 12% (15/118) vs 4% (32/849) among seronegatives. Low birthweight was associated with HIV seropositivity (-0.1kg, 95%CI -0.15, -0.04), younger maternal age (0.01kg per year increase, 95% CI 0.01,0.02), and lower gestational age (0.07kg per week increase, 95% CI 0.06,0.09), but not TPPA serostatus. The composite adverse birth outcome was associated with lower maternal and gestational age at birth. Conclusion We report high TPPA seroprevalence, low syphilis testing rates in antenatal care, and significant associations with adverse birth outcomes among WHIV in Uganda, emphasizing the need to improve prenatal syphilis testing and treatment.","PeriodicalId":501010,"journal":{"name":"The Journal of Infectious Diseases","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/infdis/jiaf453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Despite increasing syphilis incidence worldwide, little is known about the combined impact of maternal HIV and syphilis coinfection. We determined effects of HIV/syphilis coinfection in pregnancy on birth outcomes. Methods We conducted two prospective birth cohort studies of pregnant women delivering in Uganda from 2017-2023. Our primary outcome was birthweight. Our secondary outcome was a composite adverse birth outcome, including low birthweight (<2.5kg), stillbirth, early neonatal death, or 5-minute APGAR<7. We compared outcomes by HIV and Treponema pallidum particle agglutination assay (TPPA) seropositivity and fitted multivariable logistic regression models to determine associations with outcomes. Results Overall, TPPA seroprevalence was 12% (118/967) in this cohort comprised of 50% women with HIV (WHIV); 19% (94/483) among WHIV and 5% (24/484) among women without HIV. Only 48% of TPPA seropositive women reported syphilis testing during antenatal care. Combined stillbirth and early neonatal death were higher among TPPA seropositive participants: 12% (15/118) vs 4% (32/849) among seronegatives. Low birthweight was associated with HIV seropositivity (-0.1kg, 95%CI -0.15, -0.04), younger maternal age (0.01kg per year increase, 95% CI 0.01,0.02), and lower gestational age (0.07kg per week increase, 95% CI 0.06,0.09), but not TPPA serostatus. The composite adverse birth outcome was associated with lower maternal and gestational age at birth. Conclusion We report high TPPA seroprevalence, low syphilis testing rates in antenatal care, and significant associations with adverse birth outcomes among WHIV in Uganda, emphasizing the need to improve prenatal syphilis testing and treatment.
乌干达妊娠期艾滋病毒和梅毒合并感染和不良分娩结果
背景:尽管世界范围内梅毒发病率不断上升,但人们对母体HIV和梅毒合并感染的综合影响知之甚少。我们确定了妊娠期HIV/梅毒合并感染对出生结局的影响。方法:我们对2017-2023年在乌干达分娩的孕妇进行了两项前瞻性出生队列研究。我们的主要结果是出生体重。我们的次要结局是复合不良出生结局,包括低出生体重(2.5kg)、死胎、新生儿早期死亡或5分钟apgar7。我们比较了HIV和梅毒螺旋体颗粒凝集试验(TPPA)血清阳性的结果,并拟合了多变量logistic回归模型来确定与结果的关系。结果总体而言,TPPA的血清阳性率为12%(118/967),该队列由50%的HIV (WHIV)女性组成;艾滋病毒感染者占19%(94/483),未感染艾滋病毒的妇女占5%(24/484)。只有48%的TPPA血清阳性妇女报告在产前检查期间进行了梅毒检测。在TPPA血清阳性的参与者中,合并死产和新生儿早期死亡的比例更高:12%(15/118),而血清阴性的参与者中为4%(32/849)。低出生体重与HIV血清阳性(-0.1kg, 95%CI -0.15, -0.04)、较年轻的母亲年龄(每年增加0.01kg, 95%CI 0.01,0.02)和较低的胎龄(每周增加0.07kg, 95%CI 0.06,0.09)相关,但与TPPA血清状态无关。综合不良出生结局与较低的产妇和胎龄有关。结论:我们报告了TPPA血清阳性率高,产前保健中梅毒检测率低,乌干达艾滋病毒感染者与不良分娩结局有显著关联,强调需要改善产前梅毒检测和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信